124 related articles for article (PubMed ID: 35309942)
1. Pyroptosis-Related lncRNAs for Predicting the Prognosis and Identifying Immune Microenvironment Infiltration in Breast Cancer Lung Metastasis.
Liu L; Chen C; Tu G; Peng Y; Shen M; Xu Y; Liu S
Front Cell Dev Biol; 2022; 10():821727. PubMed ID: 35309942
[TBL] [Abstract][Full Text] [Related]
2. Pyroptosis-Related lncRNAs Predict the Prognosis and Immune Response in Patients With Breast Cancer.
Yang X; Weng X; Yang Y; Jiang Z
Front Genet; 2021; 12():792106. PubMed ID: 35360412
[No Abstract] [Full Text] [Related]
3. Construction and validation of an eight pyroptosis-related lncRNA risk model for breast cancer.
Tan M; Huang G; Chen J; Yi J; Liu X; Liao N; Hu Y; Zhou W; Guo Q
Am J Transl Res; 2022; 14(5):2779-2800. PubMed ID: 35702100
[TBL] [Abstract][Full Text] [Related]
4. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
Ping L; Zhang K; Ou X; Qiu X; Xiao X
Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
[No Abstract] [Full Text] [Related]
5. The Pyroptosis-Related Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Gastric Cancer.
Shao W; Yang Z; Fu Y; Zheng L; Liu F; Chai L; Jia J
Front Cell Dev Biol; 2021; 9():676485. PubMed ID: 34179006
[TBL] [Abstract][Full Text] [Related]
6. A Pyroptosis-Related Gene Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer Based on Computational Biology Techniques.
Wang Z; Bao A; Liu S; Dai F; Gong Y; Cheng Y
Front Genet; 2022; 13():801056. PubMed ID: 35464869
[TBL] [Abstract][Full Text] [Related]
7. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Xiao R; Yang M; Tan Y; Ding R; Li D
Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
[TBL] [Abstract][Full Text] [Related]
8. Identification of pyroptosis related subtypes and tumor microenvironment infiltration characteristics in breast cancer.
Huang G; Zhou J; Chen J; Liu G
Sci Rep; 2022 Jun; 12(1):10640. PubMed ID: 35739182
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and Immune Implications of a Novel Pyroptosis-Related Five-Gene Signature in Breast Cancer.
Zheng Y; Wang K; Li N; Zhang Q; Chen F; Li M
Front Surg; 2022; 9():837848. PubMed ID: 35656090
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of pyroptosis for the prognosis and immune escape of bladder cancer.
Liu Y; Pang ZQ; Han YS; Shen LK; Yao WH; Zhang L; He JX; Shan YJ; Ren MH
Am J Transl Res; 2022; 14(11):7744-7757. PubMed ID: 36505302
[TBL] [Abstract][Full Text] [Related]
11. A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs.
Huang Z; Xiao C; Zhang F; Zhou Z; Yu L; Ye C; Huang W; Li N
Front Genet; 2020; 11():634195. PubMed ID: 33584821
[No Abstract] [Full Text] [Related]
12. Comprehensive Analysis of Pyroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients with Colon Cancer.
Liu L; Chen W; Li Y; Fu P; Cao Y; Li Z; Xiong J; Jie Z
J Oncol; 2022; 2022():2035808. PubMed ID: 35087586
[TBL] [Abstract][Full Text] [Related]
13. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
Lu H; Wu J; Liang L; Wang X; Cai H
Front Immunol; 2022; 13():803355. PubMed ID: 35154117
[TBL] [Abstract][Full Text] [Related]
14. Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis.
Huang H; Shi Z; Li Y; Zhu G; Chen C; Zhang Z; Shi R; Su L; Cao P; Pan Z; Zhang H; Liu M; Liu H; Chen J
Front Oncol; 2022; 12():850943. PubMed ID: 35311148
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the Role of N6-Methylandenosine-Related Long Non-coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer.
Zhang J; Shan B; Lin L; Dong J; Sun Q; Zhou Q; Chen J; Han X
Front Cell Dev Biol; 2021; 9():711859. PubMed ID: 34692676
[TBL] [Abstract][Full Text] [Related]
16.
Zhang L; Zhang X; Zhao W; Xiao X; Liu S; Peng Q; Jiang N; Zhou B
Front Med (Lausanne); 2022; 9():760722. PubMed ID: 35308537
[TBL] [Abstract][Full Text] [Related]
17. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
18. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
19. Pyroptosis-Mediated Molecular Subtypes are Characterized by Distinct Tumor Microenvironment Infiltration Characteristics in Breast Cancer.
Xu L; Hu Y; Liu W
J Inflamm Res; 2022; 15():345-362. PubMed ID: 35079221
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer.
Lv W; Wang Y; Zhao C; Tan Y; Xiong M; Yi Y; He X; Ren Y; Wu Y; Zhang Q
Front Oncol; 2021; 11():745719. PubMed ID: 34722303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
